| Application no. and date | 16787790.1 (espacenet) (Federated) (European Patent Register), 20161021 | | Patent/reg. no. and date | DK/EP 3368017, 20191106 | | Publication date | 20180905 | | Priority no. and date | EP 15192269, 20151030 | | EP pub. no. and date |
EP 3368017 20180905 | | Effective date | | | Applicant/owner | Dr. Falk Pharma Gmbh, Leinenweberstrasse 5
79108 Freiburg, DE | | Applicant ref. no. | P41907953DK00E | | Inventor | WILHELM, Rudolph, Feuerkirschenweg 2a
76476 Bischweier, DE,
PRÖLS, Markus, Johann-von-Weerth-Strasse 11
79100 Freiburg/Breisgau, DE,
GREINWALD, Roland, Jakob-Otter-Strasse 2
79341 Kenzingen, DE,
NACAK, Tanju, Waldstrasse 9
79288 Gottenheim, DE | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/606 (2006.01) , A61K 9/20 (2006.01) , A61K 9/28 (2006.01) | | Title | Optimeret mesalazinholdig højdosistablet | | Int. application no. | EP2016075427 | | Int. publication no. | WO2017072050 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
